Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schattenberg

Showing results (331-340 of 333) with videos related to

Pageof 34
Sort By:
You have reached the last page of results.This site can display upto 333 results.
Lancet (London, England)|April 13, 2026
Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort studyIsabel Graupera, Maja Thiele, Laurent Castera, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 3, 2024
acFibroMASH Index for the Diagnosis of Fibrotic MASH and Prediction of Liver-related Events: An International Multicenter StudyGong Feng, Ferenc E Mózes, Dong Ji, et al.
Nature|March 25, 2021
NASH limits anti-tumour surveillance in immunotherapy-treated HCCDominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol, et al.
Pageof 34

Showing results (331-340 of 333) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 333 results.
Lancet (London, England)|April 13, 2026
Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort studyIsabel Graupera, Maja Thiele, Laurent Castera, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 3, 2024
acFibroMASH Index for the Diagnosis of Fibrotic MASH and Prediction of Liver-related Events: An International Multicenter StudyGong Feng, Ferenc E Mózes, Dong Ji, et al.
Nature|March 25, 2021
NASH limits anti-tumour surveillance in immunotherapy-treated HCCDominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol, et al.
Pageof 34